{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:20:06Z","timestamp":1692332406787},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Mucormycosis is an aggressive, angioinvasive fungal infection with a predilection for the rhino-orbital cavity, predominantly in immunocompromised patients such as patients with uncontrolled diabetes. Prognosis is very poor, with a survival rate of 40% to 50%; therefore, early detection and initiation of treatment is paramount. Presenting symptoms are vague and mucormycosis is rare, so recognition, awareness, and knowledge of this infection are key to timely intervention and enhanced patient survival.<\/jats:p>","DOI":"10.1097\/01.jaa.0000721656.13462.67","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T01:05:29Z","timestamp":1606266329000},"page":"23-25","source":"Crossref","is-referenced-by-count":2,"title":["Recognizing mucormycosis in an immunocompromised patient"],"prefix":"10.1097","volume":"33","author":[{"given":"Elicia","family":"Hunt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1 suppl","key":"R1-20230817","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.bbmt.2009.11.014","article-title":"Histiocytic disorders: recent insights into pathophysiology and practical guidelines","volume":"16","author":"Filipovich","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"R2-20230817","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"R3-20230817","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4274\/tjo.82474","article-title":"Rhino-orbital mucormycosis: clinical findings and treatment outcomes of four cases","volume":"45","author":"Karadeniz U\u011furlu","year":"2015","journal-title":"Turk J Ophthalmol"},{"issue":"8","key":"R5-20230817","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/alr.21714","article-title":"An evaluation of invasive fungal sinusitis outcomes with subsite analysis and use of frozen section analysis","volume":"6","author":"Foshee","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"R6-20230817","first-page":"348","article-title":"Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracranial affection and improve survival","volume":"66","author":"Plowes Hern\u00b4ndez","year":"2015","journal-title":"Acta Otorrinolaringol Esp"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000721656.13462.67","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T23:44:09Z","timestamp":1692315849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000721656.13462.67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000721656.13462.67","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}